Late referral of patients with chronic kidney disease: No time to waste

Mayo Clinic Proceedings

Volumn 81, Issue 11, 2006, Pages 1487-1494

  Sprangers, Ben ^a   Evenepoel, Pieter ^a   Vanrenterghem, Yves ^a,b  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CHRONIC KIDNEY DISEASE; DISEASE COURSE; GLOMERULUS FILTRATION RATE; HEALTH CARE COST; HUMAN; MORBIDITY; MORTALITY; PATIENT REFERRAL; PRACTICE GUIDELINE; PREVALENCE; RENAL REPLACEMENT THERAPY; REVIEW; UNITED STATES;

EID: 33750604072     PISSN: 00256196     EISSN: None     Source Type: Journal    
DOI: 10.4065/81.11.1487     Document Type: Review

References (114)

1. Coresh J, Astor BC, Greene T, Eknoyan G, Levey AS. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2003;41:1-12.
2. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year 2010. J Am Soc Nephrol. 2001;12:2753-2758.
3. Ruggenenti P, Schieppati A, Remuzzi G. Progression, remission, regression of chronic renal diseases. Lancet. 2001;357:1601-1608.
4. Remuzzi G, Bertani T. Pathophysiology of progressive nephropathies. N Engl J Med. 1998;339:1448-1456.
5. Ritz E. Heart and kidney: fatal twins? Am J Med. 2006;119(suppl 1):S31-S39.
6. Boccardo P, Remuzzi G, Galbusera M. Platelet dysfunction in renal failure. Semin Thromb Hemost. 2004;30:579-589.
7. Eadington DW. Delayed referral for dialysis. Nephrol Dial Transplant. 1996;11:2124-2126.
8. Arora P, Obrador GT, Ruthazer R, et al. Prevalence, predictors, and consequences of late nephrology referral at a tertiary care center. J Am Soc Nephrol. 1999;10:1281-1286.
9. Astor BC, Eustace JA, Powe NR, et al. Timing of nephrologist referral and arteriovenous access use: the CHOICE Study. Am J Kidney Dis. 2001;38:494-501.
10. Avorn J, Winkelmayer WC, Bohn RL, et al. Delayed nephrologist referral and inadequate vascular access in patients with advanced chronic kidney failure. J Clin Epidemiol. 2002;55:711-716.
11. Chesser AM, Baker LR. Temporary vascular access for first dialysis is common, undesirable and usually avoidable. Clin Nephrol. 1999;51:228-232.
12. Ifudu O, Dawood M, Homel P, Friedman EA. Excess morbidity in patients starting uremia therapy without prior care by a nephrologist. Am J Kidney Dis. 1996;28:841-845.
13. Schmidt RJ, Domico JR, Sorkin MI, Hobbs G. Early referral and its impact on emergent first dialyses, health care costs, and outcome. Am J Kidney Dis. 1998;32:278-283.
14. Levin A, Lewis M, Mortiboy P, et al. Multidisciplinary predialysis programs: quantification and limitations of their impact on patient outcomes in two Canadian settings. Am J Kidney Dis. 1997;29:533-540.
15. Obialo CI, Ofili EO, Quarshie A, Martin PC. Ultralate referral and presentation for renal replacement therapy: socioeconomic implications. Am J Kidney Dis. 2005;46:881-886.
16. Lameire N, Van Biesen W. The pattern of referral of patients with end-stage renal disease to the nephrologist: a European survey. Nephrol Dial Transplant. 1999;14(suppl 6):16-23.
17. Van Biesen W, Wiedemann M, Lameire N. End-stage renal disease treatment: a European perspective. J Am Soc Nephrol. 1998;9(suppl):S55-S62.
18. Schwenger V, Hofmann A, Khalifeh N, et al. Uremic patients: late referral, early death [in German]. Dtsch Med Wochenschr. 2003;128:1216-1220.
19. Kessler M, Frimat L, Panescu V, Briancon S. Impact of nephrology referral on early and midterm outcomes in ESRD: Epidemiologic de l'Insuffisance REnale chronique terminale en Lorraine (EPIREL): results of a 2-year, prospective, community-based study. Am J Kidney Dis. 2003;42:474-485.
20. Roubicek C, Brunet P, Huiart L, et al. Timing of nephrology referral: influence on mortality and morbidity. Am J Kidney Dis. 2000;36:35-41.
21. Jungers P, Zingraff J, Albouze G, et al. Late referral to maintenance dialysis: detrimental consequences. Nephrol Dial Transplant. 1993;8:1089-1093.
22. Jungers P, Joly D, Nguyen-Khoa T, Mothu N, Bassilios N, Grunfeld JP. Continued late referral of patients with chronic kidney disease: causes, consequences, and approaches to improvement [in French]. Presse Med. 2006;35:17-22.
23. Khan IH, Catto GR, Edward N, MacLeod AM. Chronic renal failure: factors influencing nephrology referral. QJM. 1994;87:559-564.
24. Metcalfe W, Khan IH, Prescott GJ, Simpson K, MacLeod AM. Can we improve early mortality in patients receiving renal replacement therapy? Kidney Int. 2000;57:2539-2545.
25. Ratcliffe PJ, Phillips RE, Oliver DO. Late referral for maintenance dialysis. Br Med J (Clin Res Ed). 1984;288:441-443.
26. Roderick P, Jones C, Drey N, et al. Late referral for end-stage renal disease: a region-wide survey in the south west of England. Nephrol Dial Transplant. 2002;17:1252-1259.
27. Halabi G, Wauters JP. Late referral for maintenance dialysis: an increasing trend with detrimental effects. Blood Purif. 1997;15(suppl 2)S18-S19.
28. Cass A, Cunningham J, Arnold PC, Snelling P, Wang Z, Hoy W. Delayed referral to a nephrologist: outcomes among patients who survive at least one year on dialysis. Med J Aust. 2002;177:135-138.
29. Sesso R, Belasco AG. Late diagnosis of chronic renal failure and mortality on maintenance dialysis. Nephrol Dial Transplant. 1996;11:2417-2420.
30. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39(suppl 1):S1-S266.
31. Wauters JP, Lameire N, Davison A, Ritz E. Why patients with progressing kidney disease are referred late to the nephrologist: on causes and proposals for improvement. Nephrol Dial Transplant. 2005;20:490-496.
32. Winkelmayer WC, Glynn RJ, Levin R, Owen W Jr, Avorn J. Late referral and modality choice in end-stage renal disease. Kidney Int. 2001;60:1547-1554.
33. Hood SA, Sondheimer JH. Impact of pre-ESRD management on dialysis outcomes: a review. Semin Dialysis. 1998;11:175-180.
34. Cockcroft DW, Gault MH. Prediction of creatinine clearance from serum creatinine. Nephron. 1976;16:31-41.
35. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D, Modification of Diet in Renal Disease Study Group. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Ann Intern Med. 1999;130:461-470.
36. Myers GL, Miller WG, Coresh J, et al; National Kidney Disease Education Program Laboratory Working Group. Recommendations for improving serum creatinine measurement: a report from the Laboratory Working Group of the National Kidney Disease Education Program. Clin Chem. 2006 Jan;52:5-18. Epub 2005 Dec 6.
37. Stevens LA, Coresh J, Greene T, Levey AS. Assessing kidney function: measured and estimated glomerular filtration rate. N Engl J Med. 2006;354:2473-2483.
38. Obrador GT, Pereira BJ. Early referral to the nephrologist and timely initiation of renal replacement therapy: a paradigm shift in the management of patients with chronic renal failure. Am J Kidney Dis. 1998;31:398-417.
39. Innes A, Rowe PA, Burden RP, Morgan AG. Early deaths on renal replacement therapy: the need for early nephrological referral. Nephrol Dial Transplant. 1992;7:467-471.
40. Fritsche L, Horstrap J, Budde K, et al. Old-for-old kidney allocation allows successful expansion of the donor and recipient pool. Am J Transplant. 2003;3:1434-1439.
41. Cassidy MJ, Sims RJ. Dialysis in the elderly: new possibilities, new problems. Minerva Urol Nefrol. 2004;56:305-317.
42. Boulware LE, Troll MU, Jaar BG, Myers DI, Powe NR. Identification and referral of patients with progressive CKD: a national study. Am J Kidney Dis. 2006;48:192-204.
43. Mendelssohn DC, Kua BT, Singer PA. Referral for dialysis in Ontario. Arch Intern Med. 1995;155:2473-2478.
44. Schramm W, Bergrem H, Cromme P, et al. First referral of diabetic patients to a nephrologist. Diabet Med. 2003;20:689-690.
45. Wong T, Foote EF, Lefavour GS, Cody RP, Brown CJ, Sherman RA. Physician knowledge and practice patterns relating to diabetic nephropathy. J Am Pharm Assoc (Wash). 1999;39:785-790.
46. Nissenson AR, Collins AJ, Hurley J, Petersen H, Pereira BJ, Steinberg EP. Opportunities for improving the care of patients with chronic renal insufficiency: current practice patterns. J Am Soc Nephrol. 2001;12:1713-1720.
47. Blake PG. Factors affecting international utilization of peritoneal dialysis: implications for increasing utilization in the United States. Semin Dialysis. 1999;12:365.
48. Wish JB. The impact of workforce issues, accountability for patient outcomes: the specialist's role in the 21st century. Part I. Nephrol News Issues. 1999;13:23, 27, 53.
49. Kausz AT, Obrador GT, Arora P, Ruthazer R, Levey AS, Pereira BJ. Late initiation of dialysis among women and ethnic minorities in the United States. J Am Soc Nephrol. 2000;11:2351-2357.
50. Levin A. Consequences of late referral on patient outcomes. Nephrol Dial Transplant. 2000;15(suppl 3):8-13.
51. Ismail N, Neyra R, Hakim R. The medical and economical advantages of early referral of chronic renal failure patients to renal specialists. Nephrol Dial Transplant. 1998;13:246-250.
52. Cass A, Cunningham J, Snelling P, Wang Z, Hoy W. Urban disadvantage and delayed nephrology referral in Australia. Health Place. 2003;9:175-182.
53. Khan SS, Xue JL, Kazmi WH, et al. Does predialysis nephrology care influence patient survival after initiation of dialysis? Kidney Int. 2005;67:1038-1046.
54. Frimat L, Loos-Ayav C, Panescu V, Cordebar N, Briancon S, Kessler M. Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal disease. Diabetes Metab. 2004;30:67-74.
55. Lin CL, Wu MS, Hsu PY, Huang CC. Improvement of clinical outcome by early nephrology referral in type II diabetics on hemodialysis. Ren Fail. 2003;25:455-464.
56. Winkelmayer WC, Owen WF Jr, Levin R, Avorn J. A propensity analysis of late versus early nephrologist referral and mortality on dialysis. J Am Soc Nephrol. 2003;14:486-492.
57. Stack AG. Impact of timing of nephrology referral and pre-ESRD care on mortality risk among new ESRD patients in the United States. Am J Kidney Dis. 2003;41:310-318.
58. Kinchen KS, Sadler J, Fink N, et al. The timing of specialist evaluation in chronic kidney disease and mortality. Ann Intern Med. 2002;137:479-486.
59. Summary for patients in: Ann Intern Med. 2002;137:I24.
60. Jungers P, Massy ZA, Nguyen-Khoa T, et al. Longer duration of predialysis nephrological care is associated with improved long-term survival of dialysis patients. Nephrol Dial Transplant. 2001;16:2357-2364.
61. Stoves J, Bartlett CN, Newstead CG. Specialist follow up of patients before end stage renal failure and its relationship to survival on dialysis. Postgrad Med J. 2001;77:586-588.
62. Avorn J, Bohn RL, Levy E, et al. Nephrologist care and mortality in patients with chronic renal insufficiency. Arch Intern Med. 2002;162:2002-2006.
63. Jungers P. Screening for renal insufficiency: is it worth while? is it feasible? Nephrol Dial Transplant. 1999;14:2082-2084.
64. Jungers P. Late referral : loss of chance for the patient, loss of money for society. Nephrol Dial Transplant. 2002;17:371-375.
65. Klahr S, Levey AS, Beck GJ, et al, Modification of Diet in Renal Disease Study Group. The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. N Engl J Med. 1994;330:877-884.
66. Peterson JC, Adler S, Burkart JM, et al, Modification of Diet in Renal Disease Study. Blood pressure control, proteinuria, and the progression of renal disease. Ann Intern Med. 1995;123:754-762.
67. Lewis EJ, Hunsicker LG, Bain RP, Rohde RD, The Collaborative Study Group. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy [published correction appears in N Engl J Med. 1993;330:152]. N Engl J Med. 1993;329:1456-1462.
68. Ismail N, Becker B, Strzelczyk P, Ritz E. Renal disease and hypertension in non-insulin-dependent diabetes mellitus. Kidney Int. 1999;55:1-28.
69. Ritz E, Rychlik I, Locatelli F, Halimi S. End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions. Am J Kidney Dis. 1999;34:795-808.
70. Giatras I, Lau J, Levey AS, Angiotensin-Converting-Enzyme Inhibition and Progressive Renal Disease Study Group. Effect of angiotensin-converting enzyme inhibitors on the progression of nondiabetic renal disease: a meta-analysis of randomized trials. Ann Intern Med. 1997;127:337-345.
71. Ruggenenti P, Perna A, Gherardi G, et al. Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria. Lancet. 1999;354:359-364.
72. Ritz E. Minor renal dysfunction: an emerging independent cardiovascular risk factor. Heart. 2003;89:963-964.
73. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
74. London GM, Drueke TB. Atherosclerosis and arteriosclerosis in chronic renal failure. Kidney Int. 1997;51:1678-1695.
75. Special report from the National Kidney Foundation Task Force on Cardiovascular Disease. Controlling the epidemic of cardiovascular disease in chronic renal disease: What do we know? What do we need to know? Where do we go from here? Am J Kidney Dis. 1998;32(suppl 3):S1-S199.
76. Levey AS. Clinical practice. Nondiabetic kidney disease. N Engl J Med. 2002;347:1505-1511.
77. Remuzzi G, Schieppati A, Ruggenenti P. Clinical practice: nephropathy in patients with type 2 diabetes. N Engl J Med. 2002;346:1145-1151.
78. Pedrini MT, Levey AS, Lau J, Chalmers TC, Wang PH. The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med. 1996;124:627-632.
79. Levey AS, Greene T, Beck GJ, et al, Modification of Diet in Renal Disease Study Group. Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? J Am Soc Nephrol. 1999;10:2426-2439.
80. Kopple JD, National Kidney Foundation K/DOQI Work Group. The National Kidney Foundation K/DOQI clinical practice guidelines for dietary protein intake for chronic dialysis patients. Am J Kidney Dis. 2001;38(suppl 1):S68-S73.
81. Kopple JD. National kidney foundation K/DOQI clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2001;37(suppl 2): S66-S70.
82. Valderrabano F, Horl WH, Jacobs C, et al. European best practice guidelines 1-4: evaluating anaemia and initiating treatment. Nephrol Dial Transplant. 2000;15(suppl 4):8-14.
83. Valderrabano F, Golper T, Muirhead N, Ritz E, Levin A. Chronic kidney disease: why is current management uncoordinated and suboptimal? Nephrol Dial Transplant. 2001;16(suppl 7):61-64.
84. Van Biesen W, De Vecchi A, Dombros N, et al. The referral pattern of end-stage renal disease patients and the initiation of dialysis: a European perspective. Perit Dial Int. 1999;19(suppl 2):S273-S275.
85. Diaz-Buxo JA. The importance of pre-ESRD education and early nephrological care in peritoneal dialysis selection and outcome. Perit Dial Int. 1998;18:363-365.
86. Diaz-Buxo JA. Modality selection. J Am Soc Nephrol. 1998;9(suppl): S112-S117.
87. Diaz-Buxo JA. Early referral and selection of peritoneal dialysis as a treatment modality. Nephrol Dial Transplant. 2000;15:147-149.
88. Prichard SS. Treatment modality selection in 150 consecutive patients starting ESRD therapy. Perit Dial Int. 1996;16:69-72.
89. Ahlmen J, Carlsson L, Schonborg C. Well-informed patients with end-stage renal disease prefer peritoneal dialysis to hemodialysis. Perit Dial Int. 1993;13(suppl 2):S196-S198.
90. Winkelmayer WC, Glynn RJ, Levin R, Mittleman MA, Pliskin JS, Avorn J. Late nephrologist referral and access to renal transplantation. Transplantation. 2002;73:1918-1923.
91. Cass A, Cunningham J, Snelling P, Ayanian JZ. Late referral to a nephrologist reduces access to renal transplantation. Am J Kidney Dis. 2003;42:1043-1049.
92. Hakim RM, Lazarus JM. Initiation of dialysis. J Am Soc Nephrol. 1995;6:1319-1328.
93. National Kidney Foundation. NKF-DOQI clinical practice guidelines for hemodialysis adequacy [published correction appears in Am J Kidney Dis. 1997;30(suppl 3):precedi]. Am J Kidney Dis. 1997;30(suppl 2):S15-S66.
94. National Kidney Foundation. NKF-DOQI clinical practice guidelines for peritoneal dialysis adequacy. Am J Kidney Dis. 1997;30(suppl 2):S67-S136.
95. Korevaar JC, Jansen MA, Dekker FW, et al, Netherlands Cooperative Study on the Adequacy of Dialysis Study Group. When to initiate dialysis: effect of proposed US guidelines on survival. Lancet. 2001;358:1046-1050.
96. Stehman-Breen CO, Sherrard DJ, Gillen D, Caps M. Determinants of type and timing of initial permanent hemodialysis vascular access. Kidney Int. 2000;57:639-645.
97. D'Cunha PT, Besarab A. Vascular access for hemodialysis: 2004 and beyond. Curr Opin Nephrol Hypertens. 2004;13:623-629.
98. Manns BJ, Taub KJ, Donaldson C. Economic evaluation and the treatment of end-stage renal disease. Curr Opin Nephrol Hypertens. 2001;10:295-299.
99. Jungers P, Choukroun G, Robino C, et al. Epidemiology of end-stage renal disease in the Ile-de-France area: a prospective study in 1998. Nephrol Dial Transplant. 2000;15:2000-2006.
100. Goransson LG, Bergrem H. Consequences of late referral of patients with end-stage renal disease. J Intern Med. 2001;250:154-159.
101. Schwab SJ, Harrington JT, Singh A, et al. Vascular access for hemodialysis. Kidney Int. 1999;55:2078-2090.
102. Fink J, Blahut S, Reddy M, Light P. Use of erythropoietin before the initiation of dialysis and its impact on mortality. Am J Kidney Dis. 2001;37:348-355.
103. Eknoyan G, Lameire N, Barsoum R, et al. The burden of kidney disease: improving global outcomes. Kidney Int. 2004;66:1310-1314.
104. Levin A. The need for optimal and coordinated management of CKD. Kidney Int Suppl. 2005;99:S7-S10.
105. Komenda P, Levin A. Analysis of cardiovascular disease and kidney outcomes in multidisciplinary chronic kidney disease clinics: complex disease requires complex care models. Curr Opin Nephrol Hypertens. 2006;15:61-66.
106. Devins GM, Mendelssohn DC, Barre PE, Taub K, Binik YM. Predialysis psychoeducational intervention extends survival in CKD: a 20-year follow-up. Am J Kidney Dis. 2005;46:1088-1098.
107. Piccoli GB, Grassi G, Mezza E, et al. Early referral of Type 2 diabetic patients: are we ready for the assault? Nephrol Dial Transplant. 2002;17:1241-1247.
108. St Peter WL, Schoolwerth AC, McGowan T, McClellan WM. Chronic kidney disease: issues and establishing programs and clinics for improved patient outcomes. Am J Kidney Dis. 2003;41:903-924.
109. Goldstein M, Yassa T, Dacouris N, McFarlane P. Multidisciplinary predialysis care and morbidity and mortality of patients on dialysis. Am J Kidney Dis. 2004;44:706-714.
110. Curtis BM, Ravani P, Malberti F, et al. The short- and long-term impact of multi-disciplinary clinics in addition to standard nephrology care on patient outcomes. Nephrol Dial Transplant. 2005 Jan;20:147-154. Epub 2004 Dec 7.
111. Mendelssohn DC. Coping with the CKD epidemic: the promise of multidisciplinary team-based care. Nephrol Dial Transplant. 2005;20:10-12.
112. Thanamayooran S, Rose C, Hirsch DJ. Effectiveness of a multidisciplinary kidney disease clinic in achieving treatment guideline targets. Nephrol Dial Transplant. 2005 Nov;20:2385-2393. Epub 2005 Jul 26.
113. Caskey FJ, Wordsworth S, Ben T, EURODICE group. Early referral and planned initiation of dialysis: what impact on quality of life? Nephrol Dial Transplant. 2003;18:1330-1338.
114. McLaughlin K, Manns B, Culleton B, Donaldson C, Taub K. An economic evaluation of early versus late referral of patients with progressive renal insufficiency. Am J Kidney Dis. 2001;38:1122-1128.